The Effectiveness of Cognitive Behaviour Therapy on Relapse in Schizophrenia Patients with Hallucinatios
Main Article Content
Abstract
Background: Schizophrenia is a chronic mental disorder characterized by psychotic symptoms such as hallucinations and delusions. Relapses in schizophrenia patients often occur even after undergoing pharmacological treatment. Cognitive Behaviour Therapy (CBT) has been reported to be effective in reducing relapses through cognitive restructuring and improving patients' coping with psychotic symptoms. This systematic review aims to assess the effectiveness of cognitive behavioral therapy (CBT) on reducing relapse rates in patients with schizophrenia, especially in hallucination.
Methods: The systematic review was conducted using the JBI approach. The included articles were primary studies with an RCT or quasi-experimental design, published between 2015 and 2024, and available in full text. The selection process was conducted using the PRISMA method, and the final results consisted of 7 articles that met the inclusion criteria.
Results: Most studies show that CBT is effective in reducing relapse, improving quality of life or social functioning, and reducing positive and negative psychotic symptoms. Culturally-based CBT and CBT by videoconference have been reported to expand access to intervention. The side effects of CBT are relatively low, but some studies report a decline in impact after therapy is discontinued.
Conclusion: CBT is effective in preventing relapse in schizophrenia patients with hallucinations by reducing psychotic symptoms and improving patient coping. Further research is needed to evaluate the long-term effectiveness of CBT.
Article Details
How to Cite
References
Allen, S., Goodall, T., Jones, C., James, R., & Surtees, A. (2023). What is the prevalence of visual hallucinations in a first-episode psychosis population? A systematic review and meta-analysis of the literature. Schizophrenia Bulletin Open, 4(1), sgad002. https://doi.org/10.1093/schizbullopen/sgad002
Bighelli, I., Çıray, O., Salahuddin, N. H., & Leucht, S. (2024). Cognitive behavioural therapy without medication for schizophrenia. Cochrane Database of Systematic Reviews, 2024(2). https://doi.org/10.1002/14651858.CD015332.pub2
Can, S. Y., & Budak, F. K. (2024). The Effect of Cognitive Behavioural Therapy–Based Psychoeducation on Medication Adherence and Aggression in Individuals Diagnosed With Schizophrenia: An Experimental Study. Journal of Psychiatric and Mental Health Nursing, 1–12. https://doi.org/10.1111/jpm.13127
Dellazizzo, L., Potvin, S., Phraxayavong, K., & Dumais, A. (2020). Exploring the benefits of virtual reality-assisted therapy following cognitive-behavioral therapy for auditory hallucinations in patients with treatment-resistant Schizophrenia: A proof of concept. Journal of Clinical Medicine, 9(10), 1–15. https://doi.org/10.3390/jcm9103169
Guaiana, G., Abbatecola, M., Aali, G., Tarantino, F., Ebuenyi, I. D., Lucarini, V., Li, W., Zhang, C., & Pinto, A. (2022). Cognitive behavioural therapy (group) for schizophrenia. Cochrane Database of Systematic Reviews, 2022(7). https://doi.org/10.1002/14651858.CD009608.pub2
Jauhar, S., Laws, K. R., & McKenna, P. J. (2019). CBT for schizophrenia: A critical viewpoint. Psychological Medicine, 49(8), 1233–1236. https://doi.org/10.1017/S0033291718004166
Jones, C., Hacker, D., Cormac, I., Meaden, A., Irving, C. B., Xia, J., Zhao, S., Shi, C., & Chen, J. (2019). Cognitive Behavioral Therapy Plus Standard Care Versus Standard Care Plus Other Psychosocial Treatments for People with Schizophrenia. Schizophrenia Bulletin, 45(2), 284–286. https://doi.org/10.1093/schbul/sby188
Kahn, R. S. (2020). On the origins of schizophrenia. American Journal of Psychiatry, 177(4), 291–297. https://doi.org/10.1176/appi.ajp.2020.20020147
Katherine Newman-Taylor, R. B. (2023). Cognitive behavioural therapy for psychosis: The end of the line or time for a new approach? The British Psychological Society. https://doi.org/DOI: 10.1111/papt.12498
Katsushima, M., Nakamura, H., Shiko, Y., Hanaoka, H., & Shimizu, E. (2025). Effectiveness of a Videoconference-Based Cognitive Behavioral Therapy Program for Patients with Schizophrenia: Pilot Randomized Controlled Trial. JMIR Formative Research, 9. https://doi.org/10.2196/59540
Keliat, B.A., Hamid A.Y.S, Putri Y.S.E, Daulima N.H.C, Wardani, I.Y, Susanti, H., Hargiana, G., Panjaitan, R.U., 2019. Asuhan Keperawatan Jiwa. Penerbit Buku Kedokteran EGC
Liu, Y., Yang, X., Gillespie, A., Guo, Z., Ma, Y., Chen, R., & Li, Z. (2019). Targeting relapse prevention and positive symptom in first-episode schizophrenia using brief cognitive behavioral therapy: A pilot randomized controlled study. Psychiatry Research, 272(December 2018), 275–283. https://doi.org/10.1016/j.psychres.2018.12.130
Mayer, S. F., Corcoran, C., Kennedy, L., Leucht, S., & Bighelli, I. (2024). Cognitive behavioural therapy added to standard care for first-episode and recent-onset psychosis. Cochrane Database of Systematic Reviews, 2024(3). https://doi.org/10.1002/14651858.CD015331.pub2
Moges, S., Belete, T., Mekonen, T., & Menberu, M. (2021). Lifetime relapse and its associated factors among people with schizophrenia spectrum disorders who are on follow up at Comprehensive Specialized Hospitals in Amhara region, Ethiopia: a cross-sectional study. International Journal of Mental Health Systems, 15(1), 1–12. https://doi.org/10.1186/s13033-021-00464-0
Morrison, A. P., Law, H., Carter, L., Sellers, R., Emsley, R., Pyle, M., French, P., Shiers, D., Yung, A. R., Murphy, E. K., Holden, N., Steele, A., Bowe, S. E., Palmier-claus, J., Brooks, V., Byrne, R., & Davies, L. (2018). Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis : a randomised controlled pilot and feasibility study. The Lancet Psychiatry, 5(5), 411–423. https://doi.org/10.1016/S2215-0366(18)30096-8
Morrison, A. P., Pyle, M., Gumley, A., Schwannauer, M., Turkington, D., MacLennan, G., Norrie, J., Hudson, J., Bowe, S. E., French, P., Byrne, R., Syrett, S., Dudley, R., McLeod, H. J., Griffiths, H., Barnes, T. R. E., Davies, L., Kingdon, D., Aydinlar, S., … Tully, S. (2018). Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial. The Lancet Psychiatry, 5(8), 633–643. https://doi.org/10.1016/S2215-0366(18)30184-6
Naeem, F., Saeed, S., Irfan, M., Kiran, T., Mehmood, N., Gul, M., Munshi, T., Ahmad, S., Kazmi, A., Husain, N., Farooq, S., Ayub, M., & Kingdon, D. (2015). Brief culturally adapted CBT for psychosis (CaCBTp): A randomized controlled trial from a low income country. Schizophrenia Research, 164(1–3), 143–148. https://doi.org/10.1016/j.schres.2015.02.015
Onitsuka, T., Hirano, Y., Nakazawa, T., Ichihashi, K., Miura, K., Inada, K., Mitoma, R., Yasui-Furukori, N., & Hashimoto, R. (2022). Toward recovery in schizophrenia: Current concepts, findings, and future research directions. Psychiatry and Clinical Neurosciences, 76(7), 282–291. https://doi.org/10.1111/pcn.13342
Owen, M., Sellwood, W., Kan, S., Murray, J., & Sarsam, M. (2015). Group CBT for psychosis: A longitudinal, controlled trial with inpatients. Behaviour Research and Therapy, 65, 76–85. https://doi.org/10.1016/j.brat.2014.12.008
Pasaribu, J., & Hasibuan, R. (2020). Medication Adherence Induced Relaps in Schizophrenic Patient. Jkj, 1(7), 39–46.
Phelan, S., & Sigala, N. (2022). The effect of treatment on insight in psychotic disorders - A systematic review and meta-analysis. Schizophrenia Research, 244(June), 126–133. https://doi.org/10.1016/j.schres.2022.05.023
Riskesdas. (2018). Laporan Riskesdas 2018 Nasional.pdf. In Lembaga Penerbit Balitbangkes (p. hal 156). https://repository.badankebijakan.kemkes.go.id/id/eprint/3514/1/Laporan Riskesdas 2018 Nasional.pdf
Shukla.P, P. D. et al. (2021). Efficacy and durability of cognitive behavior therapy in managing hallucination in patients with schizophrenia. https://doi.org/10.4103/ipj.ipj
Stuart, W Gail., Keliat, B.A, Pasaribu, J. (2023). Prinsip dan Praktik : KEPERAWATAN KESEHATAN JIWA STUART. Ed 2. Singapore : Elsevier.
Tanjung, A. I., Neherta, M., & Sarfika, R. (2022). Faktor-faktor yang Berhubungan dengan Kekambuhan Orang dengan Skizofrenia yang Berobat di Poli-Klinik Rumah Sakit Jiwa Prof. Dr. Muhammad Ildrem Medan Tahun 2021. Jurnal Ilmiah Universitas Batanghari Jambi, 22(1), 432. https://doi.org/10.33087/jiubj.v22i1.2170
Tolentino, R., & McMahon, A. (2021). The Integration of Olanzapine and Cognitive Behavioural Therapy for the Treatment of Schizophrenia: A Literature Review. Undergraduate Research in Natural and Clinical Sciences and Technology Journal, 5(1–12), 1–8. https://doi.org/10.26685/urncst.213
Valle, R. (2020). Schizophrenia in ICD-11: Comparison of ICD-10 and DSM-5. Revista de Psiquiatría y Salud Mental (English Edition), 13(2), 95–104. https://doi.org/10.1016/j.rpsmen.2020.01.002
Volk, D. W., Jenkins, A. K., & Lewis, D. A. (2025). Schizophrenia. 927–936. doi: https://doi.org/10.1016/B978-0-443-19176-3.00031-5
World Health Organization. (2025). Schizophrenia. https://www.who.int/news-room/fact-sheets/detail/schizophrenia